Lantern Pharma (LTRN) Assets

Price: $3.9
Market Cap: $42.06M
Avg Volume: 91.44K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.632
52W Range: $2.79-10.77
Website: Lantern Pharma

Lantern Pharma Asset Metrics Summary

According to Lantern Pharma's latest annual financial reports, the company's asset profile is as follows:

Total Assets

Lantern Pharma's total assets amount to $43.65M. This is divided into:

  • Total Current Assets: $43.34M
  • Total Non-current Assets: $306.29K
  • Net Receivables: $-
  • Inventory: $-
  • Cash and Short-term Investments: $41.30M
  • Property, Plant, and Equipment (Net): $280.42K
  • Long-term Investments: $-
  • Goodwill and Intangible Assets: $-

Asset Ratios and Metrics

To better understand Lantern Pharma's asset management, we can look at several key ratios:

  • Return on Assets (ROA): -36.57% - this indicates how profitable a company is relative to its total assets.
  • Asset Turnover: 0.00 - this shows how efficiently a company uses its assets to generate sales.
  • Current Ratio: 16.18 - this measures a company's ability to pay short-term obligations with its current assets.
  • Quick Ratio: 16.18 - this indicates a company's ability to meet short-term obligations with its most liquid assets.
  • Cash Ratio: 8.19 - this measures a company's ability to pay off short-term liabilities with its cash and cash equivalents.

These metrics provide insight into Lantern Pharma's asset efficiency and liquidity. For a comprehensive understanding of the company's financial health, it's important to consider these asset metrics alongside other financial indicators and industry benchmarks.

Total Assets

$43.65M

Total Current Assets

$43.34M

Total Non-current Assets

$306.29K

Net Receivables

$-

Inventory

$-

Cash and Short-term Investments

$41.30M

Property, Plant, and Equipment (Net)

$280.42K

Long-term Investments

$-

Goodwill and Intangible Assets

$-

Return on Assets

-36.57%

Asset Turnover

0.00

Current Ratio

16.18

Lantern Pharma Historical Asset Metrics
Historical Return on Assets
Historical Total Assets Growth

Lantern Pharma Historical Assets

The table below shows various asset metrics for each year, with the latest data available for the last fiscal year 2023.

Year Total Assets Total Current Assets Total Non-current Assets Net Receivables Inventory Cash and Short-term Investments Property, Plant, Equipment (Net) Long-term Investments Goodwill and Intangible Assets Return on Assets Asset Turnover Current Ratio Quick Ratio Cash Ratio
2023 $43.65M $43.34M $306.29K $- $- $41.30M $280.42K $- $- -0.37 0.00 16.18 16.18 8.19
2022 $58.84M $58.72M $113.58K $- $-592.00K $55.20M $95.69K $- $- -0.24 0.00 20.99 21.20 13.29
2021 $73.95M $72.72M $1.23M $- $-181.00K $70.73M $216.19K $1.00M $- -0.17 0.00 31.26 31.34 22.15
2020 $20.36M $20.24M $122.71K $- $- $19.23M $21.51K $- $- -0.29 0.00 36.64 36.64 34.81
2019 $1.43M $1.23M $199.76K $- $- $1.23M $8.76K $- $- -1.69 0.00 2.52 2.52 2.52
2018 $449.83K $445.16K $4.67K $- $- $445.16K $4.67K $- $- -3.84 0.00 0.68 0.68 0.68

Related Metrics

Explore detailed financial metrics and analysis for LTRN.